Jacobs Levy Equity Management’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $429K | Buy |
+41,317
| New | +$429K | ﹤0.01% | 904 |
|
|
2023
Q4 | – | Sell |
-1,083
| Closed | -$34.4K | – | 1066 |
|
|
2023
Q3 | $34.4K | Sell |
1,083
-12,694
| -92% | -$404K | ﹤0.01% | 950 |
|
|
2023
Q2 | $463K | Sell |
13,777
-3,923
| -22% | -$132K | ﹤0.01% | 834 |
|
|
2023
Q1 | $738K | Sell |
17,700
-5,837
| -25% | -$243K | ﹤0.01% | 751 |
|
|
2022
Q4 | $798K | Sell |
23,537
-497
| -2% | -$16.8K | 0.01% | 714 |
|
|
2022
Q3 | $1.18M | Sell |
24,034
-7,012
| -23% | -$345K | 0.01% | 674 |
|
|
2022
Q2 | $1.22M | Sell |
31,046
-5,980
| -16% | -$235K | 0.01% | 714 |
|
|
2022
Q1 | $1.37M | Sell |
37,026
-21,792
| -37% | -$804K | 0.01% | 702 |
|
|
2021
Q4 | $5.75M | Sell |
58,818
-8,043
| -12% | -$787K | 0.04% | 401 |
|
|
2021
Q3 | $8.34M | Sell |
66,861
-7,144
| -10% | -$892K | 0.06% | 337 |
|
|
2021
Q2 | $9.28M | Buy |
74,005
+4,639
| +7% | +$582K | 0.06% | 311 |
|
|
2021
Q1 | $9.42M | Buy |
69,366
+33,048
| +91% | +$4.49M | 0.07% | 300 |
|
|
2020
Q4 | $3.3M | Buy |
36,318
+26,581
| +273% | +$2.42M | 0.03% | 475 |
|
|
2020
Q3 | $724K | Buy |
9,737
+1,664
| +21% | +$124K | 0.01% | 722 |
|
|
2020
Q2 | $688K | Buy |
8,073
+6,886
| +580% | +$587K | 0.01% | 736 |
|
|
2020
Q1 | $86K | Buy |
+1,187
| New | +$86K | ﹤0.01% | 963 |
|
|
2019
Q1 | – | Sell |
-2,775
| Closed | -$221K | – | 1027 |
|
|
2018
Q4 | $221K | Buy |
2,775
+216
| +8% | +$17.2K | ﹤0.01% | 856 |
|
|
2018
Q3 | $1.19M | Buy |
2,559
+20
| +0.8% | +$9.33K | 0.02% | 619 |
|
|
2018
Q2 | $1.01M | Buy |
+2,539
| New | +$1.01M | 0.02% | 663 |
|